Literature DB >> 20872048

Altered expression of the natriuretic peptide system in genetically modified heme oxygenase-1 mice treated with high dietary salt.

David W J Armstrong1, M Yat Tse, Luis G Melo, Stephen C Pang.   

Abstract

Heme oxygenase-1 (HO-1) has been well established as a cytoprotective molecule, and has been shown to exert cardioprotective effects in both hypertension and cardiac hypertrophy. However, the precise mechanism of the cardioprotective effect of HO-1 has yet to be fully elucidated. With the natriuretic peptide system (NPS) as a key player in cardiovascular homeostasis and tissue dynamics, we sought to examine the effect of high dietary salt treatment in genetic models of HO-1 expression, and assessed the expression of the NPS in the left ventricle (LV), to determine if the effects of altered HO-1 expression may be due to modified levels of the NPS. Age-matched 12-week old male HO-1 knockout (HO-1(-/-)) and HO-1 cardiomyocyte-specific transgenic overexpressing (HO-1(Tg)) mice were treated with either normal salt (NS; 0.8%) or high salt (HS; 8.0%) chow for 5 weeks. LV mRNA expression was determined using quantitative real-time PCR. ANP peptide level was measured in the LV and plasma using radioimmunoassay, and LV cyclic 3'-5' guanosine monophosphate level was measured using an enzyme immunoassay kit. HO-1(-/-) fed HS diet had significantly higher left ventricle-to-body weight ratio (LV/BW) compared to HO-1(+/+) mice fed NS diet. HO-1(-/-) mice had significantly reduced expression of the NPS compared to controls, and these mice did not exhibit a salt-induced increase in ANP expression. HS treatment had no noticeable effect on LV/BW in HO-1(Tg) mice compared to controls. HO-1(Tg) mice had significantly higher ANP and BNP expression compared to controls. There were no differences in LV cGMP levels among all genotypes and dietary treatments. HO-1 ablation resulted in significantly lower mRNA expression of the NPS, whereas HO-1 overexpression resulted in higher mRNA expression of the NPS. Both were substantiated by peptide levels as measured by RIA. These data indicate that the detrimental effect of reduced HO-1 expression and the cardioprotective effect of increased HO-1 expression may be due, in part, to altered expression of the NPS.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20872048     DOI: 10.1007/s11010-010-0591-6

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.396


  37 in total

1.  Expression of B-type natriuretic peptide in atrial natriuretic peptide gene disrupted mice.

Authors:  M Y Tse; J D Watson; I R Sarda; T G Flynn; S C Pang
Journal:  Mol Cell Biochem       Date:  2001-03       Impact factor: 3.396

2.  Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A-deficient mice.

Authors:  J W Knowles; G Esposito; L Mao; J R Hagaman; J E Fox; O Smithies; H A Rockman; N Maeda
Journal:  J Clin Invest       Date:  2001-04       Impact factor: 14.808

3.  Cardiac-specific expression of heme oxygenase-1 protects against ischemia and reperfusion injury in transgenic mice.

Authors:  S F Yet; R Tian; M D Layne; Z Y Wang; K Maemura; M Solovyeva; B Ith; L G Melo; L Zhang; J S Ingwall; V J Dzau; M E Lee; M A Perrella
Journal:  Circ Res       Date:  2001-07-20       Impact factor: 17.367

4.  Heme oxygenase-1 (HO-1) inhibits postmyocardial infarct remodeling and restores ventricular function.

Authors:  Xiaoli Liu; Alok S Pachori; Christopher A Ward; J Paul Davis; Massimiliano Gnecchi; Deling Kong; Lunan Zhang; Jared Murduck; Shaw-Fang Yet; Mark A Perrella; Richard E Pratt; Victor J Dzau; Luis G Melo
Journal:  FASEB J       Date:  2006-02       Impact factor: 5.191

Review 5.  Hemoxygenase-1 in cardiovascular disease.

Authors:  Naglaa K Idriss; Andrew D Blann; Gregory Y H Lip
Journal:  J Am Coll Cardiol       Date:  2008-09-16       Impact factor: 24.094

6.  Atrial natriuretic peptide protects against ischemia-reperfusion injury in the isolated rat heart.

Authors:  Kenji Sangawa; Koji Nakanishi; Kozo Ishino; Masahiro Inoue; Masaaki Kawada; Shunji Sano
Journal:  Ann Thorac Surg       Date:  2004-01       Impact factor: 4.330

7.  Hypoxia induces severe right ventricular dilatation and infarction in heme oxygenase-1 null mice.

Authors:  S F Yet; M A Perrella; M D Layne; C M Hsieh; K Maemura; L Kobzik; P Wiesel; H Christou; S Kourembanas; M E Lee
Journal:  J Clin Invest       Date:  1999-04       Impact factor: 14.808

8.  Myocardial protection against pressure overload in mice lacking Bach1, a transcriptional repressor of heme oxygenase-1.

Authors:  Shinji Mito; Ryoji Ozono; Tetsuya Oshima; Yoko Yano; Yuichiro Watari; Yoshiyuki Yamamoto; Andrei Brydun; Kazuhiko Igarashi; Masao Yoshizumi
Journal:  Hypertension       Date:  2008-04-21       Impact factor: 10.190

9.  Heme oxygenase-1 inhibits angiotensin II-induced cardiac hypertrophy in vitro and in vivo.

Authors:  Chien-Ming Hu; Yen-Hui Chen; Ming-Tsai Chiang; Lee-Young Chau
Journal:  Circulation       Date:  2004-06-28       Impact factor: 29.690

10.  Effects of chronic salt loading on plasma atrial natriuretic peptide (ANP) in the spontaneously hypertensive rat.

Authors:  K Gradin; J Hedner; T Hedner; A C Towle; A Pettersson; B Persson
Journal:  Acta Physiol Scand       Date:  1987-01
View more
  2 in total

1.  Gestational hypertension and the developmental origins of cardiac hypertrophy and diastolic dysfunction.

Authors:  David W J Armstrong; M Yat Tse; Philip G Wong; Nicole M Ventura; Jalna A Meens; Amer M Johri; Murray F Matangi; Stephen C Pang
Journal:  Mol Cell Biochem       Date:  2014-04-10       Impact factor: 3.396

2.  Salt-Sensitive Ileal Microbiota Plays a Role in Atrial Natriuretic Peptide Deficiency-Induced Cardiac Injury.

Authors:  Siqi Li; Sishuo Chen; Min Nie; Lijing Wen; Bin Zou; Lingyu Zhang; Jingzhou Xie; Hooi-Leng Ser; Learn-Han Lee; Shunyi Wang; Caixia Lin; Janak L Pathak; Weijie Zhou; Ji Miao; Lijing Wang; Lingyun Zheng
Journal:  Nutrients       Date:  2022-07-29       Impact factor: 6.706

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.